Analyst consensus rating
Ocular Therapeutix Analyst Rating: Strong Buy
OCUL is rated Strong Buy by 11 analysts with a $27.09 target. As of 2026-08-24.
Direct answer
Ocular Therapeutix's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $27.09.
Forecast evidence checked August 24, 2026.
Get free Ocular Therapeutix email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.69
- Average price target
- $27.09
- High price target
- $34.00
- Low price target
- $18.00
- Low target gap
- +68.4%
- Target upside
- +153.4%
- High target gap
- +218.1%
- Target range width
- 149.7%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ocular Therapeutix?
Ocular Therapeutix has a verified Strong Buy consensus. The same dataset has an average price target of $27.09.
How far are Ocular Therapeutix's low and high targets from the recorded price?
The low target implies +68.4%, while the high target implies +218.1%.
How many analysts are included in Ocular Therapeutix's consensus?
The verified consensus includes 11 analysts.
How is Ocular Therapeutix's target upside or downside calculated?
The average target of $27.09 is divided by the recorded price of $10.69, then one is subtracted to produce +153.4%. This does not guarantee a future return.
When was Ocular Therapeutix's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.